Cargando…
Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019
BACKGROUND: COVID-19 caused by a novel coronavirus, a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has recently broken out worldwide. Up to now, the development of vaccine is still in the stage of clinical research, and there is no clinically approved specific antiviral drug fo...
Autores principales: | Wang, Ting, Zhao, Minghui, Ye, Pingping, Wang, Qian, Zhao, Yongshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IMSS. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833343/ https://www.ncbi.nlm.nih.gov/pubmed/33309308 http://dx.doi.org/10.1016/j.arcmed.2020.11.009 |
Ejemplares similares
-
Early Prediction of the 2019 Novel Coronavirus Outbreak in the Mainland China Based on Simple Mathematical Model
Publicado: (2020) -
Investigating ego modules and pathways in osteosarcoma by integrating the EgoNet algorithm and pathway analysis
por: Chen, X.Y., et al.
Publicado: (2017) -
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
Bioinformatics analysis of biomarkers and transcriptional factor motifs
in Down syndrome
por: Kong, X.D., et al.
Publicado: (2014) -
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the
ERK pathway
por: Bai, R.X., et al.
Publicado: (2016)